Trio Clinical Trials, LLC.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine	Ear Diseases, Nausea, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Photophobia, Sensation Disorders, Signs and Symptoms, Signs and Symptoms, Digestive, brain disorder, central nervous system disorder, eye disorder, headache disorder, hearing disorder, hyperacusis, hypnic headache, migraine disorder, nervous system disorder, otorhinolaryngologic disease, vision disorder	Recruiting	Phase 3	2026-09-24		NCT04743141
Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects	Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder	Active, not recruiting	Phase 1	2026-03-13		NCT05476497

Clinical trials